These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 22999439)

  • 21. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.
    Saykin AJ; Shtasel DL; Gur RE; Kester DB; Mozley LH; Stafiniak P; Gur RC
    Arch Gen Psychiatry; 1994 Feb; 51(2):124-31. PubMed ID: 7905258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia.
    Fatouros-Bergman H; Cervenka S; Flyckt L; Edman G; Farde L
    Schizophr Res; 2014 Sep; 158(1-3):156-62. PubMed ID: 25086658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
    Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
    Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological functioning in first-episode psychosis--evidence of specific deficits.
    Riley EM; McGovern D; Mockler D; Doku VC; OCeallaigh S; Fannon DG; Tennakoon L; Santamaria M; Soni W; Morris RG; Sharma T
    Schizophr Res; 2000 May; 43(1):47-55. PubMed ID: 10828414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome.
    Leeson VC; Robbins TW; Matheson E; Hutton SB; Ron MA; Barnes TR; Joyce EM
    Biol Psychiatry; 2009 Sep; 66(6):586-93. PubMed ID: 19576575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive function in first-episode schizophrenia.
    Hutton SB; Puri BK; Duncan LJ; Robbins TW; Barnes TR; Joyce EM
    Psychol Med; 1998 Mar; 28(2):463-73. PubMed ID: 9572103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
    Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar verbal memory impairments in schizophrenia and healthy aging. Implications for understanding of neural mechanisms.
    Silver H; Bilker WB
    Psychiatry Res; 2015 Mar; 226(1):277-83. PubMed ID: 25639372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls?
    Ojeda N; Sánchez P; Peña J; Elizagárate E; Yoller AB; Larumbe J; Gutiérrez M; Casais L; Ezcurra J
    J Nerv Ment Dis; 2010 Apr; 198(4):286-91. PubMed ID: 20386258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.
    Young JW; Powell SB; Risbrough V; Marston HM; Geyer MA
    Pharmacol Ther; 2009 May; 122(2):150-202. PubMed ID: 19269307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive functioning in the schizophrenia prodrome.
    Simon AE; Cattapan-Ludewig K; Zmilacher S; Arbach D; Gruber K; Dvorsky DN; Roth B; Isler E; Zimmer A; Umbricht D
    Schizophr Bull; 2007 May; 33(3):761-71. PubMed ID: 17412711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological profile in adult schizophrenia measured with the CMINDS.
    van Erp TG; Preda A; Turner JA; Callahan S; Calhoun VD; Bustillo JR; Lim KO; Mueller B; Brown GG; Vaidya JG; McEwen S; Belger A; Voyvodic J; Mathalon DH; Nguyen D; Ford JM; Potkin SG;
    Psychiatry Res; 2015 Dec; 230(3):826-34. PubMed ID: 26586142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.
    Kertzman S; Reznik I; Grinspan H; Weizman A; Kotler M
    Isr J Psychiatry Relat Sci; 2008; 45(2):114-20. PubMed ID: 18982837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach.
    Clissold M; Crowe SF
    J Clin Exp Neuropsychol; 2019 Feb; 41(1):26-42. PubMed ID: 30025491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.